Published in AIDS Res Treat on December 19, 2010
Supporting adherence to antiretroviral therapy with mobile phone reminders: results from a cohort in South India. PLoS One (2012) 1.48
Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis. PLoS One (2014) 1.03
Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings. BMC Public Health (2014) 0.96
Socioeconomic factors in adherence to HIV therapy in low- and middle-income countries. J Health Popul Nutr (2013) 0.95
Association between antiretroviral therapy adherence and employment status: systematic review and meta-analysis. Bull World Health Organ (2014) 0.92
Facility-level intervention to improve attendance and adherence among patients on anti-retroviral treatment in Kenya--a quasi-experimental study using time series analysis. BMC Health Serv Res (2013) 0.88
Household food insecurity associated with antiretroviral therapy adherence among HIV-infected patients in Windhoek, Namibia. J Acquir Immune Defic Syndr (2014) 0.79
Follow-Up Visit Patterns in an Antiretroviral Therapy (ART) programme in Zomba, Malawi. PLoS One (2014) 0.76
Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects. PLoS One (2017) 0.75
Treatment Buddies Improve Clinic Attendance among Women but Not Men on Antiretroviral Therapy in the Nyanza Region of Kenya. AIDS Res Treat (2016) 0.75
Clinic Attendance for Antiretroviral Pills Pick-Up among HIV-Positive People in Nepal: Roles of Perceived Family Support and Associated Factors. PLoS One (2016) 0.75
Sociodemographic profile and predictors of outpatient clinic attendance among HIV-positive patients initiating antiretroviral therapy in Selangor, Malaysia. Patient Prefer Adherence (2017) 0.75
Adherence to medication. N Engl J Med (2005) 39.77
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet (2006) 10.91
Retention in care: a challenge to survival with HIV infection. Clin Infect Dis (2007) 10.66
A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med (2001) 9.98
Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS (2003) 5.52
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS (2006) 5.13
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med (1999) 5.05
Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis (2009) 4.96
Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr (2004) 4.58
The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis (2002) 4.43
Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet (2009) 4.33
Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr (2000) 4.03
The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS (2002) 4.01
Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One (2008) 3.13
Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care (2008) 2.73
Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med (2004) 2.64
Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics (2006) 2.62
The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation (1997) 2.52
Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care (1999) 2.28
One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients. J Intern Med (2007) 2.19
Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr (2003) 2.15
Nonattendance at outpatient endoscopy. Endoscopy (2004) 2.02
Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. AIDS (2009) 1.95
Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis (2001) 1.83
Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study. AIDS (2004) 1.82
Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother (1998) 1.75
Adherence to anti-retroviral therapy among HIV patients in Bangalore, India. AIDS Res Ther (2009) 1.72
Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis (2002) 1.52
The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. J Acquir Immune Defic Syndr (2001) 1.51
Antiretroviral adherence in rural Zambia: the first year of treatment availability. Am J Trop Med Hyg (2009) 1.49
Sociodemographic characteristics associated with medical appointment adherence among HIV-seropositive patients seeking treatment in a county outpatient facility. Prev Med (2001) 1.48
Highly active antiretroviral therapy outcomes in a primary care clinic. AIDS Care (2003) 1.35
Drug-taking compliance: a review and synthesis. Health Serv Res (1978) 1.35
Measuring adherence to behavioral and medical interventions. Control Clin Trials (2000) 1.25
Clinic attendance in the hypertension detection and follow-up program. Hypertension (1982) 1.22
Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators. BMC Health Serv Res (2010) 1.22
Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol (1987) 1.16
Monitoring adherence and defaulting for antiretroviral therapy in 5 East african countries: an urgent need for standards. J Int Assoc Physicians AIDS Care (Chic) (2008) 1.14
Are untimed antiretroviral drug levels useful predictors of adherence behavior? AIDS (2004) 1.13
Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care (2004) 1.05
Urgent need for coordination in adopting standardized antiretroviral adherence performance indicators. J Acquir Immune Defic Syndr (2010) 0.97
Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multimethod approach. J Acquir Immune Defic Syndr (2010) 0.96
Self-reported reasons among HIV-infected patients for missing clinic appointments. Int J STD AIDS (2008) 0.90
Uganda runs out of antiretroviral drugs after shortfall in aid. BMJ (2009) 0.90
Nonattendance of adult otolaryngology patients for scheduled appointments. J Laryngol Otol (2006) 0.85
Compliance with oral theophylline therapy in asthmatic children. Ann Allergy (1985) 0.84
Methods for assessing compliance. Top Clin Nurs (1986) 0.77
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med (2012) 27.84
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
HIV prevention transformed: the new prevention research agenda. Lancet (2011) 4.23
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet (2010) 4.23
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 3.78
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One (2009) 3.66
Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. PLoS One (2011) 3.27
Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis (2003) 3.07
A call to action for comprehensive HIV services for men who have sex with men. Lancet (2012) 2.70
Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Med (2013) 2.44
Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime? Lancet (2008) 2.31
Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis. Lancet Infect Dis (2013) 2.18
Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria. AIDS (2013) 2.17
Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults. Trop Med Int Health (2012) 2.08
Acceptance of routine testing for HIV among adult patients at the medical emergency unit at a national referral hospital in Kampala, Uganda. AIDS Behav (2006) 2.08
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. Antivir Ther (2006) 2.02
Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review. AIDS Behav (2012) 2.01
How to get research into practice: first get practice into research. Bull World Health Organ (2007) 1.85
Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry (2010) 1.73
Using mobile phones to improve clinic attendance amongst an antiretroviral treatment cohort in rural Uganda: a cross-sectional and prospective study. AIDS Behav (2010) 1.69
Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. Int J Epidemiol (2014) 1.66
HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis (2009) 1.64
Primary mania versus HIV-related secondary mania in Uganda. Am J Psychiatry (2006) 1.62
Direct observation of treatment for tuberculosis: a randomized controlled trial of community health workers versus family members. Trop Med Int Health (2004) 1.60
Developing independent investigators for clinical research relevant for Africa. Health Res Policy Syst (2011) 1.39
Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. J Acquir Immune Defic Syndr (2008) 1.37
Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol (2007) 1.35
Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe. PLoS One (2012) 1.33
Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr (2011) 1.26
Nurse led, primary care based antiretroviral treatment versus hospital care: a controlled prospective study in Swaziland. BMC Health Serv Res (2010) 1.26
The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda. Afr Health Sci (2008) 1.25
Improving clinic attendance and adherence to antiretroviral therapy through a treatment supporter intervention in Uganda: a randomized controlled trial. AIDS Behav (2011) 1.24
Unresolved antiretroviral treatment management issues in HIV-infected children. J Acquir Immune Defic Syndr (2012) 1.17
Providing financial incentives to rural-to-urban tuberculosis migrants in Shanghai: an intervention study. Infect Dis Poverty (2012) 1.15
Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial. AIDS (2010) 1.15
Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors. J Acquir Immune Defic Syndr (2007) 1.13
Listening to those on the frontline: lessons for community-based tuberculosis programmes from a qualitative study in Swaziland. Soc Sci Med (2005) 1.13
Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience. J Acquir Immune Defic Syndr (2014) 1.11
Eligibility for HIV/AIDS treatment among adults in a medical emergency setting at an urban hospital in Uganda. Afr Health Sci (2007) 1.11
Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships. J Acquir Immune Defic Syndr (2014) 1.09
Comparing patient care seeking pathways in three models of hospital and TB programme collaboration in China. BMC Infect Dis (2013) 1.08
The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe. BMC Health Serv Res (2014) 1.08
Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe. Clin Infect Dis (2012) 1.07
Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda. PLoS One (2011) 1.06
Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda. Hum Resour Health (2009) 1.05
Research into practice: 10 years of international public health partnership between the UK and Swaziland. J Public Health (Oxf) (2010) 1.04
Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults. J Antimicrob Chemother (2012) 1.04
Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA (2004) 1.04
Liver aminotransferases and risk of incident type 2 diabetes: a systematic review and meta-analysis. Am J Epidemiol (2013) 1.04
Early-onset versus late-onset HIV-related secondary mania in Uganda. Psychosomatics (2009) 0.99
Introduction and evaluation of a 'pre-ART care' service in Swaziland: an operational research study. BMJ Open (2012) 0.99
The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda. AIDS Res Ther (2009) 0.98
An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda. J Acquir Immune Defic Syndr (2014) 0.98
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria. PLoS One (2013) 0.97
Integrating intensified case finding of tuberculosis into HIV care: an evaluation from rural Swaziland. BMC Health Serv Res (2011) 0.97
Performance of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings: a multisite study in Uganda. Trop Med Int Health (2012) 0.96
Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. J Acquir Immune Defic Syndr (2004) 0.96
Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multimethod approach. J Acquir Immune Defic Syndr (2010) 0.96
Validation of the Missoula-Vitas Quality-of-Life Index among patients with advanced AIDS in urban Kampala, Uganda. J Pain Symptom Manage (2007) 0.95
Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults. J Antimicrob Chemother (2012) 0.94
First-line antiretroviral therapy in Africa--how evidence-base are our recommendations? AIDS Rev (2005) 0.94
Knowledge and attitudes about male circumcision for HIV-1 prevention among heterosexual HIV-1 serodiscordant partnerships in Kampala, Uganda. AIDS Behav (2010) 0.93
Comparing knowledge and use of health services of migrants from rural and urban areas in Kunming City, China. J Biosoc Sci (2010) 0.92
The Infectious Diseases Institute at Makerere University, Kampala, Uganda. Infect Dis Clin North Am (2011) 0.92
Characteristics of high risk people with cardiovascular disease in Chinese rural areas: clinical indictors, disease patterns and drug treatment. PLoS One (2013) 0.91
Validation in Uganda of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings. J Acquir Immune Defic Syndr (2011) 0.91
Getting research into practice: primary care management of noncommunicable diseases in low- and middle-income countries. Bull World Health Organ (2012) 0.91
Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology (2012) 0.91
HIV/AIDS. Universal access in the fight against HIV/AIDS. Science (2010) 0.91
Assessing the quality of informed consent in a resource-limited setting: a cross-sectional study. BMC Med Ethics (2012) 0.90
Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta-analysis of prospective evidence. Diabetes Metab Res Rev (2013) 0.90
Challenges in diagnosis, treatment and follow-up of patients presenting with central nervous system infections in a resource-limited setting. Mcgill J Med (2006) 0.89
Clinical presentation and aetiologies of acute or complicated headache among HIV-seropositive patients in a Ugandan clinic. J Int AIDS Soc (2009) 0.88
Circumcision of male children for reduction of future risk for HIV: acceptability among HIV serodiscordant couples in Kampala, Uganda. PLoS One (2011) 0.88
Lifetime depressive disorders and adherence to anti-retroviral therapy in HIV-infected Ugandan adults: a case-control study. J Affect Disord (2012) 0.88
Cross-cultural adaptation and validation of the self-reporting questionnaire among HIV+ individuals in a rural ART program in southern Uganda. HIV AIDS (Auckl) (2012) 0.88
Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang. Trials (2013) 0.87
Implementation of the Chinese national microscopy centre policy: health facility survey in Shandong Province. Trop Med Int Health (2011) 0.86
Pain among ambulatory HIV/AIDS patients: multicenter study of prevalence, intensity, associated factors, and effect. J Pain (2012) 0.86
A pharmacy-only refill program at a large HIV clinic in Uganda: experience and satisfaction of patients. J Int Assoc Provid AIDS Care (2013) 0.86
Changes in pulmonary tuberculosis prevalence: evidence from the 2010 population survey in a populous province of China. BMC Infect Dis (2014) 0.85
Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in Uganda. Drug Saf (2015) 0.85